COVID-19 Screening, Testing, & Treatment At Beebe
Beebe Healthcare is proud to offer screening, testing, and treatment options for our community in the fight against COVID-19.
Beebe offers online scheduling for COVID-19 testing and COVID-19 vaccines. You are also welcome to walk into any of our Beebe Walk-In Care locations to receive your vaccine.
COVID-19 Screening: What Can I Expect?
When you come to any Beebe location, you can expect to be screened for COVID-19. You will be asked a series of questions. If you have any symptoms that might indicate COVID-19, you may be asked to consider being tested for the virus. You must also wear a face covering at all Beebe locations.
If you are not feeling well or have symptoms such as fever, cough, sore throat, body aches, gastrointestinal complaints, or headache, stay home and call your doctor. Schedule your rapid COVID-19 testing through Beebe's online scheduling system here.
Schedule your rapid COVID-19 testing at a Beebe Walk-In Care location, convenient to you: Schedule today.
There are three types of COVID-19 tests:
- SHALLOW NASAL TEST (just inside the nose): This test typically is self-administered by the individual, under the direction of testing site staff. The individual uses a swab to rub the walls of each nostril in a circular pattern.
- DEEP NASAL TEST (used by hospital systems only): This test is administered by health care providers, using what looks like a long stick with a soft brush at the end. Because the swab must go very far back to collect the cells and fluid in the passageway, the test can feel uncomfortable.
- SALIVA TEST: This test is also self-administered under staff direction. The individual being tested cannot drink, eat or brush their teeth 20 minutes before the test. The individual rubs the swab on the inside of each cheek, the gums, the roof of the mouth and the tongue.
Treatment for COVID-19
As the pandemic has continued, treating the virus has changed. There are many ways we can treat COVID-19, depending on the severity of the person's condition. Some methods for treatment once a patient is admitted to the hospital include convalescent plasma therapy and monoclonal antibody therapy.
Treating COVID-19 with Convalescent Plasma
In partnership with the Blood Bank of Delmarva, Beebe Healthcare is the first hospital in Delaware to offer convalescent plasma therapy as a treatment for acutely sick COVID-19 patients. Convalescent plasma is just one treatment method in an expanding portfolio of treatments being used today.
“This type of therapy has been around for many years. By providing antibodies, proteins that attack infection, from recovered patient’s plasma, this could help our severely sick patients a better chance to fight the COVID-19 disease,” said Dr. Bill Chasanov, Beebe’s COVID-19 Response Medical Director and Infectious Disease physician. “Beebe is proud to offer this type of treatment with the hopes of helping as many people affected by COVID-19 as possible. We have been following guidance throughout this pandemic from the CDC, WHO, FDA, and other health organization to bring the most advanced treatment options to our community in their time of need.”
The FDA guidelines allow only eligible blood donors who have recovered from COVID-19 (and have lab confirmed test) and have been asymptomatic for at least 14 days to donate their plasma. The Blood Bank of Delmarva is asking donors to be willing to donate up to three times.
Beebe is relying on the Blood Bank of Delmarva to provide the limited plasma it has available. If you are interested to see if you are eligible for a donation, visit http://delmarvablood.org/cpdonor, or call 1-888-8BLOOD-8.
Requirements to donate plasma:
- Lab confirmed positive test for COVID-19 (documentation of positive test is required)
- Your symptoms have been gone for at least 14 days
- You are willing to donate plasma (donate up to 3 times)
Monoclonal Antibody Therapy
Beebe Healthcare can provide monoclonal antibody treatment to help those at highest risk of complications from COVID-19. This treatment may help keep symptoms from becoming more serious. They may also help shorten the amount of time you are sick from COVID-19 or keep you from needing to be in the hospital. It is not a cure for COVID-19.
The United States Food and Drug Administration (FDA) has authorized this therapy for Emergency Use. The United States Government has purchased a limited number of doses and is distributing them to state health departments.
To qualify, you must:
- Have tested positive for COVID-19 within the last 5 days with either a PCR nasal swab diagnostic or rapid antigen saliva test.
- Have symptoms that are mild to moderate and have started within the last 10 days.
- Weigh at least 88 pounds and also meet at least one of the following criteria:
- Body Mass Index ≥35.
- Chronic kidney disease.
- Immunosuppressive disease (examples may include leukemia, rheumatoid arthritis or multiple sclerosis).
- Receiving immunosuppressive treatment.
- Age ≥ 65 years.
- Age ≥ 55 years AND have any of the following: cardiovascular disease, hypertension, COPD/other chronic respiratory disease.
Adolescents (age 12-17 years) must meet at least one of these criteria to qualify:
- Body Mass Index ≥85th percentile for age/gender.
- Sickle cell disease.
- Congenital (from birth) or acquired heart disease.
- Neurodevelopmental disorders (for example: cerebral palsy).
- Medical-related technological gastronomy, or positive pressure ventilation (not related to COVID-19).
- Asthma, reactive airway, or other chronic respiratory disease that requires daily medication for control.
This investigational treatment is not authorized for use in patients:
- who are hospitalized due to COVID-19; or
- who need oxygen therapy due to COVID-19; or
- who need increased oxygen due to COVID-19 or who are on chronic oxygen therapy due to a non-COVID-19 health problem.
To understand if you are a candidate for this treatment, please contact your physician directly because a physician referral is required. Please do NOT contact the hospital directly to request this treatment.